$1.43
+0.03 (+2.14%)
Open$1.38
Previous Close$1.40
Day High$1.45
Day Low$1.32
52W High$4.99
52W Low$1.16
Volume—
Avg Volume32.3K
Market Cap5.17M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+217.5% upside
Current
$1.43
$1.43
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.11M | 7.07M | 1.27M |
| Net Income | -9,930,353 | -7,790,548 | 357.5K |
| Profit Margin | -122.5% | -116.3% | 28.2% |
| EBITDA | -10,235,780 | -8,476,282 | 531.9K |
| Free Cash Flow | — | — | 275.9K |
| Rev Growth | +14.7% | +14.7% | -7.0% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |